Skip to main content

Headlines

Cullinan's Zipalertinib Combination Heads To FDA After Positive Phase 3 Lung Cancer Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Monte Rosa's MRT-8102 Drives 80%-90% NEK7 Degradation In Phase 1
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Zealand Pharma: Boehringer's Survodutide Delivers Up To 13.1% Weight Loss In Phase 3
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Pfizer's Tilrekimig Delivers Significant Skin Clearance In Phase 2 Atopic Dermatitis Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Zealand Pharma: Boehringer's Survodutide Meets Phase 3 Endpoints In Obesity & Diabetes Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Genentech's Giredestrant Posts Positive Phase 3 Data Ahead Of November, December FDA Dates
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lundbeck's Phase IV Trial Of Eptinezumab Meets Primary Goal In Migraine After Prior CGRP Therapy
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Pfizer's Tilrekimig Meets Phase 2 Primary Endpoint In Atopic Dermatitis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lundbeck Reports Positive Phase IV THRIVE Results For Eptinezumab In Migraine
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Corvus Begins Patient Enrollment In Phase 1b Soquelitinib Trial For Hidradenitis Suppurativa
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Monte Rosa Set To Report MRT-8102 Phase 1 Data In Cardiovascular Risk Study Today; Stock Up
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lilly's EloraTZP Delivers Weight Loss Results In Phase 2b Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Jade Biosciences Advances JADE301 Toward Phase 1 Trial In Dermatomyositis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Silexion Doses First Patient In Phase 2/3 SIL204 Trial For Pancreatic Cancer
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lilly's EBGLYSS Shows Rapid Skin Clearance And Symptom Relief In Phase 3b Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks